Tabelle S8 aus einem in vivo CRISPR-Screen identifiziert, dass SNRPC das Fortschreiten von triple-negativem Brustkrebs fördert.

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Table S8 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression2024
2. 2Table S7 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression2024
3. 3Table S7 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression2024
4. 4Table S1 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression2024
5. 5Table S1 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression2024